Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice was added announcing an NIH website transition and stating that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T12:52:32.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:42:42.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:29.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, indicating access is blocked. The additions include the HTML structure of a 403 page (title, header, and footer) rather than substantive study details.
    Difference
    21%
    Check dated 2026-09-20T20:25:41.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a small deployment update with no documented changes to the study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-08-30T21:43:29.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The study page now displays a server error page with a basic HTML frame. This replaces the full study record and related content on the page.
    Difference
    20%
    Check dated 2026-08-09T11:19:50.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.